These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35311710)

  • 1. You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research.
    Largent EA; Bhardwaj T; Clapp JT; Sykes OS; Harkins K; Grill JD
    J Alzheimers Dis; 2022; 90(3):1021-1033. PubMed ID: 35311710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Reluctance to Share Alzheimer's Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment?
    Cox CG; Ryan MM; Gillen DL; Grill JD
    J Prev Alzheimers Dis; 2021; 8(1):52-58. PubMed ID: 33336225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Alzheimer's Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer's-Focused Studies.
    Langbaum JB; High N; Nichols J; Kettenhoven C; Reiman EM; Tariot PN
    J Prev Alzheimers Dis; 2020; 7(4):242-250. PubMed ID: 32920626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Elicitation Study to Understand Black, Hispanic, and Male Older Adults' Willingness to Participate in Alzheimer's Disease-Focused Research Registries.
    Bleakley A; Maloney EK; Harkins K; Nelson MN; Akpek E; Langbaum JB
    J Alzheimers Dis; 2022; 88(4):1499-1509. PubMed ID: 35811525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "From Victimhood to Warriors": Super-researchers' Insights Into Alzheimer's Disease Clinical Trial Participation Motivations.
    Bardach SH; Parsons K; Gibson A; Jicha GA
    Gerontologist; 2020 May; 60(4):693-703. PubMed ID: 31322657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data.
    Amariglio RE; Sikkes SAM; Marshall GA; Buckley RF; Gatchel JR; Johnson KA; Rentz DM; Donohue MC; Raman R; Sun CK; Yaari R; Holdridge KC; Sims JR; Grill JD; Aisen PS; Sperling RA
    J Prev Alzheimers Dis; 2021; 8(3):257-262. PubMed ID: 34101781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Community Engaged Digital Alzheimer's Research (CEDAR) Study: A Digital Intervention to Increase Research Participation of Black American Participants in the Brain Health Registry.
    Mindt MR; Ashford MT; Zhu D; Cham H; Aaronson A; Conti C; Deng X; Alaniz R; Sorce J; Cypress C; Griffin P; Flenniken D; Camacho M; Fockler J; Truran D; Mackin RS; Hill C; Weiner MW; Byrd D; Turner Ii RW; Nosheny RL
    J Prev Alzheimers Dis; 2023; 10(4):847-856. PubMed ID: 37874107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical research participation among aging adults enrolled in an Alzheimer's Disease Center research registry.
    Jefferson AL; Lambe S; Chaisson C; Palmisano J; Horvath KJ; Karlawish J
    J Alzheimers Dis; 2011; 23(3):443-52. PubMed ID: 21116048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.
    Walter S; Langford OG; Clanton TB; Jimenez-Maggiora GA; Raman R; Rafii MS; Shaffer EJ; Sperling RA; Cummings JL; Aisen PS
    J Prev Alzheimers Dis; 2020; 7(4):234-241. PubMed ID: 32920625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study partners should be required in preclinical Alzheimer's disease trials.
    Grill JD; Karlawish J
    Alzheimers Res Ther; 2017 Dec; 9(1):93. PubMed ID: 29212555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD).
    Walter S; Clanton TB; Langford OG; Rafii MS; Shaffer EJ; Grill JD; Jimenez-Maggiora GA; Sperling RA; Cummings JL; Aisen PS
    J Prev Alzheimers Dis; 2020; 7(4):219-225. PubMed ID: 32920623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer's disease: study partner vs. participant accuracy.
    Ryan MM; Grill JD; Gillen DL;
    Alzheimers Res Ther; 2019 Oct; 11(1):85. PubMed ID: 31627738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and facilitators to participating in Alzheimer's disease biomarker research in black and white older adults.
    Eliacin J; Polsinelli AJ; Epperson F; Gao S; Van Heiden S; Westmoreland G; Richards R; Richards M; Campbell C; Hendrie H; Risacher SL; Saykin AJ; Wang S
    Alzheimers Dement (N Y); 2023; 9(2):e12399. PubMed ID: 37287470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study partners: essential collaborators in discovering treatments for Alzheimer's disease.
    Largent EA; Karlawish J; Grill JD
    Alzheimers Res Ther; 2018 Sep; 10(1):101. PubMed ID: 30261910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials.
    Grill JD; Zhou Y; Elashoff D; Karlawish J
    Neurobiol Aging; 2016 Mar; 39():147-53. PubMed ID: 26923411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention.
    Udeh-Momoh C; Zheng B; Sandebring-Matton A; Novak G; Kivipelto M; Jönsson L; Middleton L
    J Prev Alzheimers Dis; 2022; 9(1):12-21. PubMed ID: 35098969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing a Memory Clinic Model to Facilitate Recruitment into Early Phase Clinical Trials for Mild Cognitive Impairment and Alzheimer's Disease.
    Park L; Kouhanim C; Lee S; Mendoza Z; Patrick K; Gertsik L; Aguilar C; Gullaba D; Semenova S; Jhee S
    J Prev Alzheimers Dis; 2019; 6(2):135-138. PubMed ID: 30756120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
    Langbaum JB; Karlawish J; Roberts JS; Wood EM; Bradbury A; High N; Walsh TL; Gordon D; Aggarwal R; Davis P; Stowell C; Trisko L; Langlois CM; Reiman EM; Tariot PN
    Alzheimers Dement; 2019 Apr; 15(4):515-524. PubMed ID: 30772251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of study partner on the conduct of Alzheimer disease clinical trials.
    Grill JD; Raman R; Ernstrom K; Aisen P; Karlawish J
    Neurology; 2013 Jan; 80(3):282-8. PubMed ID: 23255824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.